Madrigal Pharma (MDGL) – Hot FDA News
-
Madrigal Pharma (MDGL) Confirms FDA Approval of Rezdiffra for Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis
-
Madrigal Pharma (MDGL): FDA Approves rezdiffra
-
-
-
-
-
Back to MDGL Stock Lookup